389 related articles for article (PubMed ID: 28727678)
41. Progress toward measles elimination in the Eastern Mediterranean Region.
Naouri B; Ahmed H; Bekhit R; Teleb N; Mohsni E; Alexander JP
J Infect Dis; 2011 Jul; 204 Suppl 1():S289-98. PubMed ID: 21666176
[TBL] [Abstract][Full Text] [Related]
42. International measles incidence and immunization coverage.
Hall R; Jolley D
J Infect Dis; 2011 Jul; 204 Suppl 1():S158-63. PubMed ID: 21666157
[TBL] [Abstract][Full Text] [Related]
43. Accelerating measles elimination and strengthening routine immunization services in Guizhou Province, China, 2003-2009.
Zuo S; Cairns L; Hutin Y; Liang X; Tong Y; Zhu Q; Zhang D; Lee LA; Strebel P; Quick L
Vaccine; 2015 Apr; 33(17):2050-5. PubMed ID: 25769207
[TBL] [Abstract][Full Text] [Related]
44. Progress in implementing measles mortality reduction strategies--India, 2010-2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Sep; 60(38):1315-9. PubMed ID: 21956408
[TBL] [Abstract][Full Text] [Related]
45. Progress in measles and rubella elimination in Iran.
Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
[TBL] [Abstract][Full Text] [Related]
46. Progress toward measles mortality reduction and elimination--Eastern Mediterranean Region, 1997-2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Mar; 57(10):262-7. PubMed ID: 18340334
[TBL] [Abstract][Full Text] [Related]
47. Progress Toward Regional Measles Elimination - Worldwide, 2000-2021.
Minta AA; Ferrari M; Antoni S; Portnoy A; Sbarra A; Lambert B; Hauryski S; Hatcher C; Nedelec Y; Datta D; Ho LL; Steulet C; Gacic-Dobo M; Rota PA; Mulders MN; Bose AS; Perea WA; O'Connor P
MMWR Morb Mortal Wkly Rep; 2022 Nov; 71(47):1489-1495. PubMed ID: 36417303
[TBL] [Abstract][Full Text] [Related]
48. Progress toward measles elimination in the People's Republic of China, 2000-2009.
Ma C; An Z; Hao L; Cairns KL; Zhang Y; Ma J; Cao L; Wen N; Xu W; Liang X; Yang W; Luo H
J Infect Dis; 2011 Jul; 204 Suppl 1():S447-54. PubMed ID: 21666198
[TBL] [Abstract][Full Text] [Related]
49. Antecedent causes of a measles resurgence in the Democratic Republic of the Congo.
Scobie HM; Ilunga BK; Mulumba A; Shidi C; Coulibaly T; Obama R; Tamfum JJ; Simbu EP; Smit SB; Masresha B; Perry RT; Alleman MM; Kretsinger K; Goodson J
Pan Afr Med J; 2015; 21():30. PubMed ID: 26401224
[TBL] [Abstract][Full Text] [Related]
50. Measles resurgence in southern Africa: challenges to measles elimination.
Shibeshi ME; Masresha BG; Smit SB; Biellik RJ; Nicholson JL; Muitherero C; Shivute N; Walker O; Reggis K; Goodson JL
Vaccine; 2014 Apr; 32(16):1798-807. PubMed ID: 24530936
[TBL] [Abstract][Full Text] [Related]
51. Measles in the 21st Century: Progress Toward Achieving and Sustaining Elimination.
Gastañaduy PA; Goodson JL; Panagiotakopoulos L; Rota PA; Orenstein WA; Patel M
J Infect Dis; 2021 Sep; 224(12 Suppl 2):S420-S428. PubMed ID: 34590128
[TBL] [Abstract][Full Text] [Related]
52. Measles-Rubella Supplementary Immunization Activity Readiness Assessment - India, 2017-2018.
Gurnani V; Haldar P; Khanal S; Bhatnagar P; Singh B; Ahmed D; Samiuddin M; Kumar A; Negi Y; Gupta S; Harvey P; Bahl S; Dabbagh A; Alexander JP; Goodson JL
MMWR Morb Mortal Wkly Rep; 2018 Jul; 67(26):742-746. PubMed ID: 29975677
[TBL] [Abstract][Full Text] [Related]
53. Descriptive study of measles vaccination second dose reporting and barriers to improving coverage in six districts in Malawi.
Chirwa G; Wilkins KA; Mercer DJ
Pan Afr Med J; 2020; 35(Suppl 1):5. PubMed ID: 32373256
[TBL] [Abstract][Full Text] [Related]
54. A scorecard of progress towards measles elimination in 15 west African countries, 2001-19: a retrospective, multicountry analysis of national immunisation coverage and surveillance data.
Wariri O; Nkereuwem E; Erondu NA; Edem B; Nkereuwem OO; Idoko OT; Agogo E; Enegela JE; Sesay T; Conde IS; Kaucley L; Awuah AA; Abdullahi S; Luce RR; Banda R; Nomhwange T; Kampmann B
Lancet Glob Health; 2021 Mar; 9(3):e280-e290. PubMed ID: 33607028
[TBL] [Abstract][Full Text] [Related]
55. Progress in global measles control and mortality reduction, 2000-2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Dec; 57(48):1303-6. PubMed ID: 19052529
[TBL] [Abstract][Full Text] [Related]
56. Strengthening routine immunization through measles-rubella elimination.
Biellik RJ; Orenstein WA
Vaccine; 2018 Sep; 36(37):5645-5650. PubMed ID: 30041881
[TBL] [Abstract][Full Text] [Related]
57. Progress towards measles elimination -South-East Asia Region, 2003-2013.
Wkly Epidemiol Rec; 2015 Jun; 90(24):297-305. PubMed ID: 26072524
[No Abstract] [Full Text] [Related]
58. Increased transmission and outbreaks of measles--European Region, 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(47):1605-10. PubMed ID: 22129994
[TBL] [Abstract][Full Text] [Related]
59. Global Measles and Rubella Laboratory Network, January 2004-June 2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Nov; 54(43):1100-4. PubMed ID: 16267497
[TBL] [Abstract][Full Text] [Related]
60. Progress toward sustainable measles mortality reduction--South-East Asia Region, 1999-2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Jul; 53(25):559-62. PubMed ID: 15229414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
